Pattern of p63 expression in squamous cell carcinoma of the oral cavity

Virchows Archiv

Volumn 444, Issue 4, 2004, Pages 332-339

  Foschini, Maria P ^a,b   Gaiba, Alessia ^a   Cocchi, Roberto ^b   Pennesi, Maria G ^b   Gatto, Maria R ^a   Frezza, Giovanni P ^a   Pession, Annalisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Oral cavity; p63; Prognosis; Squamous cell carcinoma

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P63;

ADULT; AGED; ARTICLE; CELL COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 2142717369     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0969-x     Document Type: Article

References (19)

1. Association of Directors of Anatomic and Surgical Pathology (2000) Recommendations for reporting of specimens containing oral cavity and oropharynx. Virchows Arch 437:345-347
2. Augustin M, Bamberger C, Paul D, Schmale H (1998) Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome. Mamm Genom 9:899-902
3. Chilosi M, Zamò A, Brighenti A, Malpelli G, Montagna L, Piccoli P, Pedron S, Lestani M, Inghirami G, Scarpa A, Doglioni M, Menestrina F (2003) Constitutive expression of ΔN-p63α isofonn in human thymus and thymic epithelial tumours. Virchows Archiv 443:175-183
4. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, EP-Naggar AK (2002) Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 33:158-164
5. DiComo C, Marshall JU, Babayan I, Drobnyak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501
6. Flores ER, Tsal KY, Crowely D, Sengupta S, Yang A, McKeon F, Jacks T (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564
7. Nylander K, Coates P, Hall PA (2000) Characterization of the malignant expression pattern of p63α and ΔNp63α in benign and malignant oral epithelial lesions. Int J Cancer 87:368-372
8. Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G (2002) p63 immunoreactiviry in lung cancer: yet another player in the development of squamous cell carcinoma? J Pathol 198:100-109
9. Pruneri G, Pignataro L, Manzotti M, Carboni N, Ronchetti D, Neri A, Cesana BM, Viale G (2002) P63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down regulation in tumorigenesis and lack of prognostic implication for p63 immunoreactivity. Lab Invest 82:1327-1334
10. Reis-Filho JS, Simpson PT, Martins A, Preto An Gartner F, Schmitt F (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Archiv 443:122-132
11. Schmale H, Bamberger C (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene 15:1363-1367
12. Senoo M, Seki N, Ohira M, Suyano S, Watanabe M, Inuzuka S, Okamoto T, Tachibana M, Tanaka T, Shinkay T, Kato H (1998) A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Comun 248:603-607
13. Senoo M, Tsuchiya I, Matsumara Y, Mori T, Saito Y, Kato H, Okamoto T, Habu S (2001) Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell cardnomas: expression of ΔNp73L, a novel dominant-negative isoform, and loss of expression of the potential tumor suppressor p51. Br J Cancer 84:1235-1241
14. Shimada A, Kato S, Enjo K, Osada M, Ikawa Y, Kohno K, Obinata M, Kanamaru R, Ikawa S, Ishioka C (1999) The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Canc Res 59:2781-2786
15. Urist MJ, DiComo CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, Cordon-Cardo C (2002) Loss of p63 expression in association with tumor progression in bladder cancer. Am J Pathol 161:1199-1206
16. Wang BY, Gil J, Kaufman D, Gan L, Khots DS, Burstain DE (2002) p63 in pulmonary epithelium, pulmonary squamous neoplasm, and other pulmonary tumors. Hum Pathol 33:921-926
17. Wu M, Wang B, Gil J, Sabo E, Miller I, Gan L, Burtein DE (2003). P63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of the lung from poorly differentiated squamous cell carcinoma of the lung. Am J Clin Pathol 119:696-702
18. Yang A, McKeon F (2000) p63 and p73: p53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199-207
19. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316